Financhill
Sell
36

JANX Quote, Financials, Valuation and Earnings

Last price:
$25.24
Seasonality move :
2.62%
Day range:
$24.71 - $26.46
52-week range:
$22.48 - $71.71
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
110.03x
P/B ratio:
1.47x
Volume:
1.2M
Avg. volume:
1M
1-year change:
-41.38%
Market cap:
$1.5B
Revenue:
$10.6M
EPS (TTM):
-$1.36

Earnings Data

Next earnings date for JANX
Aug 07
2025
Most recent earnings per share
-$0.38
Beat by $0.01
(May 8/2025)
Consensus Estimate
-$0.39
(May 8/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

JANX Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
08/07/2025 Q2 $300K -- -- -$0.48 --
05/08/2025 Q1 $650K -- -$0.38 -$0.39 $0.01
12/31/2024 Q4 $1.3M -- -$0.36 -$0.45 $0.09
11/06/2024 Q3 $1.6M $439K -$0.51 -$0.36 -$0.15
08/07/2024 Q2 $863.1K $8.9M -$0.11 -$0.29 $0.18
05/08/2024 Q1 $1M $1.3M -$0.30 -$0.33 $0.03
03/08/2024 Q4 $739.3K $2.5M -$0.24 -$0.39 $0.15
11/07/2023 Q3 -- -- -$0.25 -$0.43 $0.18
08/08/2023 Q2 -- -- -$0.42 -$0.51 $0.09
05/09/2023 Q1 -- -- -$0.42 -$0.47 $0.05
03/10/2023 Q4 -- -- -$0.39 -$0.50 $0.11
11/10/2022 Q3 -- -- -$0.40 -$0.53 $0.13
08/09/2022 Q2 -- -- -$0.41 -$0.39 -$0.02
05/10/2022 Q1 -- -- -$0.32 -- --
03/18/2022 Q4 -- -- -$0.33 -- --
11/09/2021 Q3 -- -- -$0.26 -- --
08/10/2021 Q2 -- -- -$0.62 -- --
03/31/2021 Q1 -- -- -$0.06 -- --
12/31/2020 Q4 -- -- -$0.13 -- --
09/30/2020 Q3 -- -- -$0.10 -- --
06/30/2020 Q2 -- -- -$0.20 -- --
03/31/2020 Q1 -- -- -$0.11 -- --

Janux Therapeutics Earnings Questions

  • How Much did Janux Therapeutics Generate in Revenue Last Quarter?

    Janux Therapeutics reported -- worth of top line sales in its most recent quarter.

  • Did Janux Therapeutics Beat Earnings Last Quarter?

    Janux Therapeutics announced earnings per share of -$0.38 which represents a beat of analyst forecast a -$0.39 per share.

  • Is Janux Therapeutics Profitable?

    Janux Therapeutics reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for Janux Therapeutics EPS Next Year?

    Janux Therapeutics's earnings are forecast to decrease from -$1.28 per share to -$1.30 per share next year representing a decrease of -65.09%.

  • When is Janux Therapeutics's Earnings Date?

    Janux Therapeutics's next earnings date is August 7, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Rambus (RMBS) Stock Forecast, Can the Rally Continue in 2025?
Rambus (RMBS) Stock Forecast, Can the Rally Continue in 2025?

Rambus has flown under the radar, but the numbers tell…

Celsius Stock Forecast: Will Earnings Spark Another Surge?
Celsius Stock Forecast: Will Earnings Spark Another Surge?

Energy drink seller Celsius Holdings, Inc. (NASDAQ:CELH) has reported somewhat…

Will DigitalOcean Stock Bounce Back?
Will DigitalOcean Stock Bounce Back?

DigitalOcean (NYSE:DOCN) has run into the proverbial brick wall with…

Stock Ideas

Buy
65
Is MSFT Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 38x

Buy
65
Is NVDA Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 45x

Sell
33
Is AAPL Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 32x

Alerts

Buy
60
MRUS alert for May 24

Merus NV [MRUS] is up 32.55% over the past day.

Buy
57
RGC alert for May 24

Regencell Bioscience Holdings [RGC] is up 28.43% over the past day.

Buy
90
OKLO alert for May 24

Oklo [OKLO] is up 23.11% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock